SCHEMBL26065805

SCHEMBL26065805

Cc1nc(C(F)(F)F)ccc1S(=O)(=O)N1CCN(CC2CCCO2)CC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.44
▸ KDM4E B2RXH2 7/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ HPGD P15428 2/20 0.44
▸ ADRB2 P07550 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ TRPV4 Q9HBA0 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ATM Q13315 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25372869 0.87 TRPV4 (0.42) ALDH1A1KDM4EHSD17B10HPGDADRB2
SCHEMBL25372864 0.87 TRPV4 (0.42) ALDH1A1KDM4EHSD17B10HPGDADRB2
SCHEMBL26066191 0.87 USP2 (0.41) ALDH1A1KDM4EHSD17B10HPGDADRB2
SCHEMBL26065774 0.84 TLR7 (0.42) ALDH1A1KDM4EMAPK1CNR2TRPV4
SCHEMBL26065889 0.84 EBP (0.44) CNR2TRPV4
SCHEMBL26065891 0.82 TRPV4 (0.41) ALDH1A1KDM4EHPGDMAPK1TRPV4
SCHEMBL26065762 0.82 EBP (0.39) ALDH1A1KDM4EHSD17B10HPGDMAPK1
SCHEMBL26065920 0.82 EBP (0.39) ALDH1A1KDM4EHSD17B10HPGDMAPK1
SCHEMBL26065919 0.82 EBP (0.39) ALDH1A1KDM4EHSD17B10HPGDMAPK1
SCHEMBL26065776 0.81 TRPV4 (0.38) ALDH1A1KDM4EADRB2MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 — — WO disclosed
Send feedback